Drug factory · FDA FEI 3005026214
Corden Pharma Lisbon, S.A.
Rua da Indústria, 2, Amadora, Portugal
Problems found, fixed voluntarily at FDA's last inspection, Apr 21, 2022.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2022: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Bismuth Cation and Metronidazole and Tetracycline | Packages it | H2-Pharma LLC | 61269-381, 61269-386 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 21, 2022 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.